Effect of birid triple viable on peptic ulcer patients with Helicobacter pylori infection.
10.3969/j.issn.1672-7347.2010.09.017
- Author:
Canxia XU
1
;
Lijun XIAO
;
Huifang ZOU
Author Information
1. Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha, China. xucanxia2000@hotmail.com
- Publication Type:Journal Article
- MeSH:
Adult;
Amoxicillin;
administration & dosage;
Anti-Bacterial Agents;
administration & dosage;
Anti-Ulcer Agents;
administration & dosage;
Drug Administration Schedule;
Drug Therapy, Combination;
Esomeprazole;
administration & dosage;
Female;
Furazolidone;
administration & dosage;
Helicobacter Infections;
drug therapy;
Helicobacter pylori;
drug effects;
isolation & purification;
Humans;
Lactobacillus acidophilus;
physiology;
Male;
Peptic Ulcer;
drug therapy;
microbiology
- From:
Journal of Central South University(Medical Sciences)
2010;35(9):1000-1004
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the effect of birid triple viable on peptic ulcer patients with Helicobacter pylori(H.pylori) infection.
METHODS:A total of 120 peptic ulcer patients with H.pylori infection was randomly divided into 2 groups. The control group was treated with the triple therapy including Esomeprazole, Amoxicillin, and Furazolidone. The treatment group was treated with the same triple therapy plus birid triple viable. The pH values of the gastric juice, bacterial culture of the gastric juice, the therapy-related side effects and the healing rate of ulcer and erosive were observed before the treatment and after a 14-day-treatment respectively. The (14)C-urea breath test((14)C-UBT) was used to evaluate the H.pylori eradication rates 4 weeks after the treatment.
RESULTS:After the treatment, pH values of the gastric juice in both groups were significantly higher than those before the treatment (P<0.05). When pH values of the gastric juice ≥4, the positive rate of bacterial culture in the treatment group was lower than that of the control group (80.0% and 97.4% respectively, P<0.05). The rate of adverse effects in the treatment group was lower than that in the control group (11.7% and 30% respectively, P<0.05).After a 2-week treatment, the healing rate of ulcer and erosion was 80% and 68.7% in the treatment group, and 73.3% and 40.7% in the control group. The healing rate of ulcer had no significant difference in the 2 groups (P>0.05),while the healing rate of erosion in the treatment group was higher than that of the control group (P<0.05).The H.pylori eradication rates evaluated by per-protocol (PP) analysis in the treatment group was significantly higher than that of the control group (80.4% and 62.4% respectively, P<0.05).
CONCLUSION:The combined use of birid triple viable and the triple therapy of H.pylori in peptic ulcer patients with H.pylori infection can reduce the bacteria of the gastric juice and therapy-related side effects. It can increase the H.pylori eradication rate and promote the healing of erosion.
